We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong’s Latest All-in-one Molecular Diagnosis system - Panall 8000 Open System

By LabMedica International staff writers
Posted on 14 May 2024
Print article
Image: Tianlong Panall 8000 is an open system that enables laboratories to program user-defined PCR analysis protocols.
Image: Tianlong Panall 8000 is an open system that enables laboratories to program user-defined PCR analysis protocols.

New achievement! We are excited to announce that Tianlong’s Panall 8000 All-in-one Molecular Diagnosis system is now OPEN to be compatible with PCR reagents from different manufacturers. The open system now enables laboratories to program user-defined PCR analysis protocols, and allows you to test a wide range of sample types and meet emerging diagnostic requirements through customized reagents.

Tianlong Panall 8000 is an open system that enables laboratories to program user-defined PCR analysis protocols. Laboratories can use user-defined protocols in addition to those developed by Tianlong. The simple and efficient design of the Tianlong Panall 8000 allows you to test a wide range of sample types and meet emerging diagnostic requirements through customized reagents. Tianlong intends to work with our partners to bring more new tests to the Panall 8000 for detection of a broad range of disease categories.

Features of Panall 8000 Open System:

Compatible with PCR reagents from different manufacturers:
Empty PCR tubes work with your PCR reagents

Customize collaboration mode for a more diversified menu
Tianlong will collaborate with our partners to jointly expand the testing menu. Tianlong can customize nucleic acid extraction reagents to match your PCR reagents for more business possibilities.

Available for more application scenarios
An open system with a diversified testing menu can meet your emerging diagnostic reguirements and apply in more scenarios. Tianlong Panall 8000 compatible with your reagents can optimize the detection process with minimal hands-on time and make detection more efficient

Extensive Testing Menu: Respiratory infection, Gastrointestinal infections, Sexually transmitted infections, and Customized reagents

Learn more about Tianlong’s Panall 8000:
https://www.medtl.net/products/open-system-panall-8000-all-in-one-molecular-diagnosis-system.html

#IVD #PCR #Health #MolecularDiagnostics #GeneticTesting


New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Rickettsia Conorii Assay
RICKETTSIA CONORII ELISA

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.